Anemia
Intravenous iron was safe and effective in pediatric patients with iron deficiency anemia and inflammatory bowel disease.
Delaying treatment for SAA until genetic testing for IBMFS may be detrimental in patients with negative workup and history.
The MAA for RP-L102, an investigational gene therapy for Fanconi anemia, has been approved by the EMA.
Dr. Sharathkumar shared data from her 2024 ASPHO presentation on romiplostim in children with severe aplastic anemia and MDS.
The European Commission approved an expanded indication for luspatercept as first-line therapy for anemia in lower-risk MDS.
The US FDA has approved vadadustat to treat anemia due to CKD in adults who have been on dialysis for at least three months.
The US FDA ODAC voted that the benefits of imetelstat for managing anemia in lower-risk MDS outweigh the risks.
Iptacopan monotherapy improved hematologic and clinical outcomes of persistent anemia in patients with PNH.
Advertisement
Expert Interviews on Hematology
Advertisement
